Jun 11, 2018
Galmed Pharmaceuticals to Host Conference Call to Discuss Top-Line, 52-Week Results from the Global Phase 2b ARREST Study
May 09, 2018
Galmed Pharmaceuticals Provides Business Update and Reports First Quarter 2018 Financial Results
May 01, 2018
Galmed Pharmaceuticals to Report First Quarter 2018 Financial Results and Provide Business Update on Wednesday, May 9
Apr 16, 2018
Galmed Pharmaceuticals to Host Post-EASL Key Opinion Leader Call on the Scientific Rationale and Clinical Development of Aramchol(TM) for NASH
Apr 03, 2018
Galmed Pharmaceuticals Announces Pricing of $6.0 Million Registered Direct Offering
Mar 27, 2018
Galmed Pharmaceuticals to Present New Scientific Data on the Mechanism by Which Aramchol Exerts its Effect on Fibrosis at EASL
Mar 13, 2018
Galmed Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update
Mar 05, 2018
Galmed Pharmaceuticals to Report Full Year and Fourth Quarter 2017 Financial Results and Provide Business Update on Tuesday, March 13
Mar 02, 2018
Galmed Pharmaceuticals to Participate in Investor Conferences in March
Feb 14, 2018
Galmed Announces ARRIVE Study Data
Feb 08, 2018
Galmed Pharmaceuticals to Provide Corporate Update at the LEERINK Partners 7th Annual Global Healthcare Conference
Feb 07, 2018
Galmed Granted "Preferred Technological Enterprise" Status Which may Provide the Company With Significant Financial Benefits
Jan 02, 2018
Galmed Pharmaceuticals Raised Gross Proceeds of $11.6 Million Under ATM Programs During December 2017
Nov 27, 2017
Galmed Pharmaceuticals to Present at HEP DART 2017 Meeting
Nov 09, 2017
Galmed Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update
Nov 07, 2017
Galmed Pharmaceuticals to Provide Corporate Overview at the Stifel 2017 Healthcare Conference
Nov 01, 2017
Galmed Pharmaceuticals to Report Third Quarter Financial Results on Thursday, November 9th
Oct 19, 2017
Galmed Pharmaceuticals to Host Key Opinion Leader Meeting on Non-Alcoholic Steato-Hepatitis (NASH)
Oct 05, 2017
Galmed Pharmaceuticals Announces Publication of Data on Aramchol(TM) Mechanism of Action in Hepatology Communications. Data Will Also Be Presented at AASLD
Aug 03, 2017
Galmed Pharmaceuticals Announces Pricing of Offering of Ordinary Shares to Existing Investors and Members of the Board of Directors